(Q39860990)

15 September 2017

P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta (English)

1 reference

15 September 2017

0 references

4

1 reference

15 September 2017

Leon M Tai

1

1 reference

PubMed ID

19367293

15 September 2017

A Jane Loughlin

series ordinal

2

1 reference

PubMed ID

19367293

15 September 2017

David K Male

series ordinal

3

1 reference

15 September 2017

15 April 2009

1 reference

Journal of Cerebral Blood Flow & Metabolism

15 September 2017

1 reference

15 September 2017

29

1 reference

15 September 2017

6

1 reference

15 September 2017

1079-1083

1 reference

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model

15 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

Localisation of breast cancer resistance protein in microvessel endothelium of human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

beta-Amyloid efflux mediated by p-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

Clearance of amyloid-beta by circulating lipoprotein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

The blood-brain barrier in health and chronic neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

inferred from DOI database lookup

7 January 2021

based on heuristic

Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.42

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JCBFM.2009.42

1 reference

15 September 2017

1 reference

PubMed ID

19367293